We concluded that ROS-induced damage to DNA and chromosomes promotes tumor progression mainly via alterations in ribosome biogenesis as well as via activation of the Wnt/β-Catenin and TGF-β1/Smad signaling pathways. The gene discussed is TGFB1; the disease is neoplasm.